Nkarta (NKTX) Interest Coverage Ratio (2019 - 2026)
Nkarta's (NKTX) quarterly Interest Coverage Ratio came in at 5.15 in Q1 2026, up 21.88% year-on-year from 4.22 in Q1 2025, and down 1.17% quarter-over-quarter from 5.09 in Q4 2025.
Nkarta (NKTX) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Nkarta's Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 5.15 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 21.88% year-over-year to 5.15 in Q1 2026; TTM through Mar 2026 was 5.19, a 27.0% decrease from a year earlier, with the FY2025 full-year figure at 0.81, up 87.21% from the prior year.
- Interest Coverage Ratio declined to 5.15 in Q1 2026 per NKTX's latest filing, from 5.09 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.2 in Q3 2023 and bottomed at 43.5 in Q1 2022.
- The 5-year median for Interest Coverage Ratio is 5.09 (2025), against an average of 5.76.
- Across the five-year window, Interest Coverage Ratio jumped 97.66% in 2022 and tumbled 2562.48% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 8.77 in 2022, then jumped by 77.43% to 1.98 in 2023, then tumbled by 227.15% to 6.48 in 2024, then advanced by 21.49% to 5.09 in 2025, then slipped by 1.17% to 5.15 in 2026.
- Per Business Quant, the three latest NKTX Interest Coverage Ratio figures stand at 5.15 (Q1 2026), 5.09 (Q4 2025), and 0.74 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | -157.58 |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 3.88 |
| 10 | Nkarta | 176.36 Mn | 176.36 Mn | - | -5.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.15 |
| Dec 31, 2025 | -5.09 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | -0.70 |
| Mar 31, 2025 | -6.59 |
| Dec 31, 2024 | -6.48 |
| Sep 30, 2024 | -5.43 |
| Jun 30, 2024 | -5.33 |
| Mar 31, 2024 | -1.06 |
| Dec 31, 2023 | -1.98 |
| Sep 30, 2023 | -0.20 |
| Jun 30, 2023 | -0.25 |
| Mar 31, 2023 | -5.92 |
| Dec 31, 2022 | -8.77 |
| Sep 30, 2022 | -0.50 |
| Jun 30, 2022 | -0.23 |
| Mar 31, 2022 | -43.50 |
| Dec 31, 2021 | -35.82 |
| Sep 30, 2021 | -1.29 |
| Jun 30, 2021 | -9.91 |